Atea Pharmaceuticals, Inc. (AVIR) stock
AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.96+0.03 (+0.76%)
Close on Nov 20, 2026Market cap $317.61MP/E –Yield –
Atea Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Atea Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2022 was -$122.93M. For fiscal 2022 it was -$122.93M. The highest annual figure on record is $296.71M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$122.93M | – |
| FY2021 | Dec 31, 2021 | -$87.01M | -129.3% |
| FY2020 | Dec 31, 2020 | $296.71M | – |
| FY2019 | Dec 31, 2019 | -$12.83M | – |
| FY2018 | Dec 31, 2018 | -$7.92M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$21.55M | -106.8% |
| Q3 FY2022 | Sep 30, 2022 | -$21.26M | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.07M | – |
| Q1 FY2022 | Mar 31, 2022 | -$59.05M | – |
| Q4 FY2020 | Dec 31, 2020 | $318.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.94M | – |
See a number that looks wrong?